News

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...
After declaring Chapter 11 bankruptcy in May of 2025, once-giant WeightWatchers (rebranded to WW beginning in 2018) admitted ...
The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead.
The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
Researchers say GLP-1 medicines might be able to help with migraines.